Skip to main content
. 2013 Dec 4;8(12):e81858. doi: 10.1371/journal.pone.0081858

Figure 2. Hazard ratios (HRs) of progression-free survival and overall survival.

Figure 2

(A) HRs of progression-free survival for GOG-0218 and ICON7; (B) HRs of progression-free survival for OCEANS and AURELIA; (C) HRs of overall survival for GOG-0218 and ICON7. Bev: bevacizumab; chemo: chemotherapy.